Stock price when the opinion was issued
Shares are down because the market fears they will do a tie-up deal with Humana, but CI bowed out. This is good given Human's problems. Managers are excellent, making good deals. EPS grew 13% compounded annual growth rate from 2013-2023. Are buying back shares and pay a dividend.
(Analysts’ price target is $397.05)
Health care insurance space, global. A company wanted to buy them and it was rejected by the US government, but they have until next April for the deal to go through. 14 times earnings. They help companies save money. Once the deal does close, or doesn’t, they will have the ability to raise the dividend.